The Food and Drug Administration acted on Monday to expand Pfizer-BioNTech’s emergency use authorization for its COVID-19 vaccine to include kids ages 12-15.
The Food and Drug Administration acted on Monday to expand Pfizer-BioNTech’s emergency use authorization for its COVID-19 vaccine to include kids ages 12-15.
